633316-75-3 Usage
Chemical structure
The compound has a unique structure that contains a cyclopropyl ring and a triazoloazocine ring system.
Potential pharmaceutical applications
Due to its ability to interact with various biological targets, the compound has potential pharmaceutical applications.
Medicinal chemistry research
The compound may be used in medicinal chemistry research to design new drugs with enhanced pharmacological properties.
Modulation of biological pathways
The compound's ability to modulate certain biological pathways may make it a promising candidate for the development of novel therapeutic agents.
Further research
Further research into the compound's biological activities and potential applications is warranted to fully understand its pharmacological potential.
Molecular weight
The molecular weight of the compound is approximately 377.29 g/mol.
Appearance
The compound is likely to be a solid at room temperature, although the exact appearance is not specified in the material provided.
Solubility
The solubility of the compound is not specified in the material provided, but it may be soluble in organic solvents such as ethanol or dimethyl sulfoxide (DMSO).
Stability
The stability of the compound is not specified in the material provided, but it may be sensitive to light, heat, or moisture and should be stored under appropriate conditions to maintain its stability.
Safety
The safety profile of the compound is not specified in the material provided, but it should be handled with care and appropriate safety measures should be taken to minimize exposure to the compound.
Synthesis
The synthesis of the compound is not specified in the material provided, but it may involve the formation of the cyclopropyl ring and the triazoloazocine ring system through a series of chemical reactions.
Biological targets
The compound may interact with various biological targets, although the specific targets are not specified in the material provided.
Pharmacological properties
The compound may have enhanced pharmacological properties, although the specific properties are not specified in the material provided.
Therapeutic agents
The compound may be a promising candidate for the development of novel therapeutic agents, although the specific therapeutic applications are not specified in the material provided.
Check Digit Verification of cas no
The CAS Registry Mumber 633316-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,3,3,1 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 633316-75:
(8*6)+(7*3)+(6*3)+(5*3)+(4*1)+(3*6)+(2*7)+(1*5)=143
143 % 10 = 3
So 633316-75-3 is a valid CAS Registry Number.
633316-75-3Relevant academic research and scientific papers
Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
Zhu, Yuping,Olson, Steven H.,Graham, Donald,Patel, Gool,Hermanowski-Vosatka, Anne,Mundt, Steven,Shah, Kashmira,Springer, Marty,Thieringer, Rolf,Wright, Samuel,Xiao, Jianying,Zokian, Hratch,Dragovic, Jasminka,Balkovec, James M.
body text, p. 3412 - 3416 (2009/04/06)
3-(Phenylcyclobutyl)-1,2,4-triazoles were identified as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). These were active both in vitro and in an in vivo mouse pharmacodynamic (PD) model. Fluorine substitution of the cyclobutan
